The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
- PMID: 17559085
- DOI: 10.1002/jcp.21162
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
Abstract
The transcriptional coactivator p300 is a ubiquitous nuclear phosphoprotein and transcriptional cofactor with intrinsic acetyltransferase activity. p300 controls the expression of numerous genes in cell-type and signal-specific manner, and plays a pivotal role in cellular proliferation, apoptosis, and embryogenesis. By catalyzing acetylation of histones and transcription factors, p300 plays a significant role in epigenetic regulation. Recent evidence suggests that abnormal p300 function is associated with deregulated target gene expression, and is implicated in inflammation, cancer, cardiac hypertrophy, and genetic disorders such as the Rubinstein-Taybi syndrome. The activity of p300 is regulated at multiple levels, including developmental stage-specific expression, post-translational modifications, subcellular localization, and cell-type and gene-specific interactions with transcription factors. Although p300 has been investigated extensively in epithelial and hematopoietic cells, its role in fibroblast biology and tissue repair has received little attention to date. Recent studies implicate p300 in the regulation of collagen synthesis by transforming growth factor-beta (TGF-beta). Both the acetyltransferase activity of p300 and its inducible interaction with Smad3 are essential for mediating TGF-beta-induced stimulation of collagen synthesis. As a signal integrator whose availability for intracellular interactions with transcription factors is strictly limiting, p300 mediates the antagonistic regulation of TGF-beta-induced collagen synthesis by IFN-gamma and TNF-alpha via intracellular competition for limiting amount of p300. Significantly, p300 is itself a direct transcriptional target of TGF-beta in normal fibroblasts, and its levels are significantly elevated in fibrotic lesions as well as in experimental models of fibrosis. The emerging appreciation of the importance of p300 in extracellular matrix (ECM) remodeling and fibrosis and novel insights concerning the regulation, mechanism of action, and significance of p300 in fibroblast biology are discussed in this minireview.
2007 Wiley-Liss, Inc.
Similar articles
-
Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.Arthritis Rheum. 2005 Apr;52(4):1248-58. doi: 10.1002/art.20996. Arthritis Rheum. 2005. PMID: 15818659
-
The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells.J Biol Chem. 2004 Nov 12;279(46):47455-63. doi: 10.1074/jbc.M403477200. Epub 2004 Sep 1. J Biol Chem. 2004. PMID: 15345715
-
Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.Oncogene. 2000 Jul 20;19(31):3546-55. doi: 10.1038/sj.onc.1203693. Oncogene. 2000. PMID: 10918613
-
Fibrosis: is it a coactivator disease?Front Biosci (Elite Ed). 2012 Jan 1;4(4):1556-70. doi: 10.2741/e480. Front Biosci (Elite Ed). 2012. PMID: 22201975 Review.
-
EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs.Int J Mol Sci. 2023 Aug 1;24(15):12302. doi: 10.3390/ijms241512302. Int J Mol Sci. 2023. PMID: 37569677 Free PMC article. Review.
Cited by
-
Cell signals influencing hepatic fibrosis.Int J Hepatol. 2012;2012:158547. doi: 10.1155/2012/158547. Epub 2012 Aug 29. Int J Hepatol. 2012. PMID: 22973518 Free PMC article.
-
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.Arthritis Rheumatol. 2015 May;67(5):1323-34. doi: 10.1002/art.39061. Arthritis Rheumatol. 2015. PMID: 25707573 Free PMC article.
-
Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives.Curr Rheumatol Rep. 2019 Dec 7;21(12):69. doi: 10.1007/s11926-019-0877-y. Curr Rheumatol Rep. 2019. PMID: 31813068 Review.
-
Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy.Bioinformatics. 2023 Nov 1;39(11):btad666. doi: 10.1093/bioinformatics/btad666. Bioinformatics. 2023. PMID: 37930015 Free PMC article.
-
JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.Br J Pharmacol. 2020 Jul;177(13):2959-2973. doi: 10.1111/bph.15023. Epub 2020 Mar 23. Br J Pharmacol. 2020. PMID: 32060899 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous